Cancer | Gene | Protein | Substrate type | Editing residue (s) | References |
---|---|---|---|---|---|
Hepatocellular carcinoma | AZIN1 | Antizyme inhibitor 1 | Coding gene | S/G | [62] |
BLCAP | Bladder cancer-associated protein | Coding gene | Y/C | [68] | |
ITGA2 | Integrin alpha 2 | Coding gene | Â | [70] | |
circARSP91 | Â | circRNA | circRNA | ||
Esophageal squamous cell carcinoma | AZIN1 | Antizyme inhibitor 1 | Coding gene | S/G | [73] |
Colorectal carcinoma | AZIN1 | Antizyme inhibitor 1 | Coding gene | S/G | |
Gastric cancer | hsa_circ_0004872 | Â | circRNA | circRNA | [76] |
Pancreatic ductal adenocarcinoma | circNEIL3 | Â | circRNA | circRNA | [77] |
Non-small-cell lung cancer | AZIN1 | Antizyme inhibitor 1 | Coding gene | S/G | [65] |
Lung adenocarcinoma | FAK | Focal adhesion kinase | Intron | Â | [34] |
Multiple myeloma | GLI1 | Glioma-associated oncogene 1 | Coding gene | R/G | [78] |
NEIL1 | Endonuclease 8-like 1 | Coding gene | K/R | [79] | |
Melanoma | CCNI | Cyclin I | Coding gene | R/G | [24] |
miR-455-5p | Â | miRNA | miRNA | [69] | |
miR-378a-3p | Â | miRNA | miRNA | [80] | |
miR-222 | Â | miRNA | miRNA | [81] | |
miRNA-149-3p | Â | miRNA | miRNA | [82] | |
Breast invasive carcinoma | GABRA3 | Gamma-aminobutyric acid receptor subunit alpha-3 | Coding gene | I/M | [67] |
ARHGAP26 | RhoA GTPase activating protein 26 | 3′ UTR | 3′ UTR | [83] | |
DHFR | Dihydrofolate reductase | 3′ UTR | 3′ UTR | [84] | |
DFFA | DNA fragmentation factor alpha | 3′ UTR | 3′ UTR | [27] | |
LINC00944 | Â | LncRNA | lncRNA | [85] | |
Cervical squamous cell carcinoma and endocervical adenocarcinoma | BLCAP | Bladder cancer-associated protein | Coding gene | Y/C; Q/R; K/R | [86] |
Thyroid cancer | CDK13 | Â | Coding gene | Q/R | |
miR-200b | Â | miRNA | miRNA | [89] | |
Prostate adenocarcinoma | PCA3 | Prostate cancer antigen 3 | LncRNA | Duplex with PRUNE2 | [90] |
Chronic myelogenous leukemia | pri-let-7d | Â | Â | Â | [91] |